Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|May 1, 2004
- Volume 0 0
Statins Help in Stroke Recovery
Advertisement
Stroke patients may benefit from taking statins, concluded the authors of a study reported in BMC Medicine (March 23, 2004). The researchers observed 433 ischemic stroke patients admitted to the US National Institute of Neurological Disorders and Stroke Program at Suburban Hospital in Bethesda, Md. Their study showed that 51% of the patients taking statins when admitted to the hospital were discharged with no major disability, compared with 38% of those not taking statins on arrival at the hospital.
Articles in this issue
over 22 years ago
Aging Brings Changesover 22 years ago
RxPRODUCT NEWS PROFILE: Cubicinover 22 years ago
Can You Read These Rxs?over 22 years ago
Treatment of Sexually Transmitted Diseasesover 22 years ago
Pharmacist Misappropriates Trade Secretsover 22 years ago
Topiramate May Reduce Frequency and Severity of Migraine Headachesover 22 years ago
HRT Is Linked to Breast Cancer Relapseover 22 years ago
Psoriasis May Be Treated Safely and Effectively with AdalimumabAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
4
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
5